| Date Filed | Type | Description |
| 06/02/2023 |
4
| Nosenzo John (Director) has filed a Form 4 on TELA Bio, Inc.|
Txns:
| Granted 3,135 shares
@ $0
Granted 5,360 options to buy
@ $10.34, valued at
$55.4k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Nosenzo John (Chief Commercial Officer) has filed a Form 4 on Bioventus Inc.|
Txns:
| Sold 65,963 shares
@ $11.1199, valued at
$733.5k
Exercised 106,485 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Nosenzo John (Chief Commercial Officer) has filed a Form 4 on Bioventus Inc.|
Txns:
| Sold 534 shares
@ $11.9875, valued at
$6.4k
Exercised 1,470 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Nosenzo John (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Bioventus Inc.|
Txns:
| Paid exercise price by delivering 24,205 shares
@ $12.88, valued at
$311.8k
Exercised 66,139 options to buy
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Nosenzo John (Chief Commercial Officer) has filed a Form 4 on Bioventus Inc.|
Txns:
| Granted 1,470 restricted stock units
@ $0 |
|
| 02/11/2021 |
3
| Nosenzo John (Chief Commercial Officer) has filed a Form 3 on Bioventus Inc. |